Quark Venture: Funding, Team & Investors | Startup Intros

Loading organizations...

Quark Venture: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 1, 2022	Alpha9 Theranostics	$75.0M Series B	Melissa McCracken, PhD	Atlas Venture, F-Prime Capital Partners, Frazier Healthcare Partners, Ed Mathers, Nextech Invest, OrbiMed, Samsara BioCapital, BVF Partners, Patrick Heron, Matthew Young
Feb 1, 2022	Koneksa Health	$45.0M Series C	Matrix Capital Management	4BIO Capital, Takeda Ventures, McKesson Ventures, Merck, Novartis, Velosity Capital, Waterline Ventures
Jun 24, 2021	Lyndra Therapeutics	$60.5M Series C	Geoffrey Cornell, CFA	Catalytic Impact Foundation, Gilead Sciences, HOPU Investments, Invus, Limitless Ventures, Mass General Brigham Ventures, Polaris Partners, Yipinhong Pharmaceutical (USA)
Apr 1, 2021	Volastra Therapeutics	$32.0M Seed	—	NanoDimension, Polaris Partners, ARCH Venture Partners, Catalio Capital Management, Droia Ventures, Amy Schulman, Vida Ventures
Mar 15, 2021	Variantyx	$20.0M Series C	Zafrira Avnur	20/20 HealthCare Partners, IBM Ventures, New Era Capital Partners, Pitango Venture Capital
Mar 11, 2021	CalciMedica	$21.0M Series D	GF Securities, Karimah Es Sabar	Sanderling Ventures, Valence Life Sciences
Jan 1, 2020	Eyevensys	$30.0M Series B	Boehringer Ingelheim	Pureos Bioventures, Bpifrance, Neena Kadaba, Inserm Transfert, Karista, Pontifax, Dominik Escher
Dec 1, 2019	Raziel Therapeutics	$22.0M Series C	Pontifax	Catalyst Fund, Docor International Management, Peregrine Investments, Karimah Es Sabar, Wille Finance
Apr 1, 2018	V-Wave	$70.0M Wave - Series C	Deerfield Management	Aperture Venture Partners, BioStar Ventures, BRM Group, Edwards Lifesciences, Endeavour Vision, Israel Secondary Fund, Johnson & Johnson Innovation, Pontifax, Pura Vida Investments, Triventures
Feb 1, 2018	ABAC Therapeutics	$20.0M Series A	Pontifax Venture Capital	Faber, Carlos Esteban, Bea Arnold, Olga Fidalgo, Zafrira Avnur
Dec 18, 2017	ARTMS	$3.0M Other Equity	GF Securities, Karimah Es Sabar	—
Oct 2, 2017	CathWorks	$15.8M Series B	Quark Venture, Triventures	BioStar Ventures, Planven Entrepreneur Ventures, Pontifax
Oct 1, 2017	Bioarray Therapeutics	$4.0M Series B	—	Connecticut Innovations, GF Securities, Karimah Es Sabar
Jul 25, 2017	physIQ	$8.0M Series B	Daniel Malven	GF Securities, LionBird, Zafrira Avnur
Jun 1, 2017	PHEMI	$10.0M Series B	BDC Capital, CTI Life Sciences Fund, GF Securities, Karimah Es Sabar	Amplitude VC
Apr 13, 2017	Lyndra Therapeutics	$23.0M Series A	Polaris Partners	GF Securities, Healthlink Capital, Mass General Brigham, Suffolk Equity, Yonghua Capital
Jan 27, 2017	Biscayne NeuroTherapeutics	$3.0M Series B	Karimah Es Sabar	Carey J. Ng
Dec 1, 2016	SQZ Biotech	$4.0M Series B	—	Google Ventures, NanoDimension, Polaris Partners, Karimah Es Sabar
Oct 6, 2016	MSI Methylation Sciences	$30.0M Other Equity	Quark Venture	—